43 results
8-K
PTPI
Petros Pharmaceuticals Inc
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm
.
In connection with the Private Placement, pursuant to an Engagement Letter (the “Engagement Letter”), between the Company and Katalyst Securities LLC
8-K
PTPI
Petros Pharmaceuticals Inc
24 Jan 22
Entry into a Material Definitive Agreement
8:00am
) between the parties before it can be offered for commercial sale.
The Agreement contains general terms governing the parties’ engagement and provides
424B3
PTPI
Petros Pharmaceuticals Inc
19 Sep 23
Prospectus supplement
4:36pm
, by and among the Company and the investors listed therein (the “Investors”), and an engagement agreement (the “Engagement Agreement”), dated July 13 … to sexual engagement, with or without food when using the 100mg or 200mg dosing (does not apply to 50mg dosing). Petros is also currently conducting
8-K
PTPI
Petros Pharmaceuticals Inc
12 Jan 24
Changes in Registrant's Certifying Accountant
4:32pm
. In connection with the engagement, Marcum will prepare the report on the Company’s consolidated financial statements for the year ended December 31
8-K
EX-10.1
c3a5iusg
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
S-8
EX-99.1
emtedxydjy8p12b ku
22 Dec 22
Registration of securities for employees
5:03pm
DEF 14A
2faok
22 Nov 21
Definitive proxy
4:37pm
PRE 14A
fbn4hn3oedp
30 Sep 22
Preliminary proxy
4:45pm
8-K
EX-3.2
zh1x1va7ulotd l9
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am